United Arab Emirates (UAE) Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

United Arab Emirates (UAE) Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report: “United Arab Emirates (UAE) Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on the analysis of the healthcare, regulatory and reimbursement landscape in UAE. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The United Arab Emirates (UAE) pharmaceutical industry has considerable development potential for international drugmakers, as the second-largest economy among Arab countries, after Saudi Arabia. The trend in market preferences toward generic drugs and other medical products may influence the future trajectory of the UAE pharmaceuticals sector, as enterprises increasingly attempt to produce generics to keep up with current market dynamics. In terms of US dollars, the pharmaceutical market increased from $2.9 billion in 2017 to $3.5 billion in 2020, at a compound annual growth rate (CAGR) of 7.0%. The market is expected to grow further at a CAGR of 7.2% from 2021 to $5.6 billion in 2027. The UAE is home to the regional headquarters and production sites of the majority of the world's leading global pharmaceutical businesses. In 2016, the medical devices market in the UAE was worth $1.3 billion, which increased at a CAGR of 12.7% to $2.4 billion in 2021. It is further expected to grow at a CAGR of 3.9% from 2022, reaching $2.9 billion in 2027. Sphere, an e-public health system for epidemiological monitoring and administration that was developed by the UAE's Ministry of Health and Prevention (MOHAP), was introduced during Dubai's Arab Health 2022 exhibition. It includes epidemiological analysis, detecting illness patterns and seasons, calculating critical indicators and utilizing them to make evidence-based choices, and developing epidemiological maps to address future hazards.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in UAE, and includes -

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
• Profiles and SWOT analyses of the major players in the pharmaceutical market: Johnson & Johnson, Roche, Boehringer Ingehlheim, Merck, and Julphar.
• Profiles and SWOT analyses of the major players in the medical device market: Abbott, B Braun, Zimmer Biomet, Terumo, and Smith & Nephew.
• An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
• Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure.
• An overview of the opportunities for and challenges to growth in the UAE’s healthcare market.

Reasons to BuyThis report will enhance your decision-making capability by allowing you to -

• Develop business strategies by understanding the trends shaping and driving the UAE healthcare market
• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the UAE healthcare market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership